Literature DB >> 4621013

Simultaneous determination of 3,4-dihydroxyphenylacetic acid and homovanillic acid in milligram amounts of rat striatal tissue by gas-liquid chromatography.

E Watson, B Travis, S Wilk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4621013     DOI: 10.1016/0024-3205(74)90033-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  6 in total

1.  Atypical antidopaminergic properties of CI-686: a potential antipsychotic agent.

Authors:  M Stanley; J Rotrosen; N Sculerati; S Gershon; C Kuhn; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

2.  Dopamine metabolites in human brain.

Authors:  S Wilk; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

3.  Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.

Authors:  R R McInnes; S Kaufman; J J Warsh; G R Van Loon; S Milstien; G Kapatos; S Soldin; P Walsh; D MacGregor; W B Hanley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

4.  Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.

Authors:  I M McIntyre; C Kuhn; S Demitriou; F R Fucek; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; G R Breese; R B Mailman
Journal:  J Chromatogr       Date:  1981-10-09

6.  Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding.

Authors:  J L Waddington; A J Cross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.